Phosphohistone H3 outperforms Ki67 as a marker of outcome for breast cancer patients-Reference-Cited by-同舟云学术

Phosphohistone H3 outperforms Ki67 as a marker of outcome for breast cancer patients

Author:

Gerring Zac¹²,Pearson John F³,Morrin Helen R¹,Robinson Bridget A⁴⁵,Harris Gavin C⁶,Walker Logan C¹

Affiliation:

1. Department of Pathology; University of Otago, Christchurch; Christchurch New Zealand

2. Neurogenetics Laboratory; Genetics and Computational Biology Division; QIMR Berghofer Institute of Medical Research; Brisbane Qld Australia

3. Biostatistics and Computational Biology Unit; University of Otago; Christchurch New Zealand

4. Department of Medicine; University of Otago; Christchurch New Zealand

5. Canterbury Regional Cancer and Haematology Service; Christchurch New Zealand

6. Department of Anatomical Pathology; Canterbury District Health Board; Christchurch New Zealand

Funder

Mackenzie Charitable Foundation

Estate of Patricia McDonald

Cancer Society of New Zealand Canterbury West-Coast Division

Publisher

Wiley

Subject

General Medicine,Histology,Pathology and Forensic Medicine

Link

Reference28 articles.

3. Phosphohistone H3: new standard IHC marker for grading tumors via mitotic indexing;Yang;MLO Med. Lab. Obs.,2011

4. Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67;Gerdes;J. Immunol.,1984

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献